Clinical Trial Update: SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients [Phase 4]

View source ↗

Summary

Phase 4 trial SAFE-CRP evaluating structural changes and endothelial function in cardiovascular risk patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hypertension

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Coronary Arteriosclerosis | Phase 4 | Status: TERMINATED